ANI Pharmaceuticals Inc. (ANIP)
54.22
0.29 (0.54%)
At close: Jan 14, 2025, 3:59 PM
54.16
-0.11%
After-hours Jan 14, 2025, 04:00 PM EST
Company Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada.
It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations.
The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies.
It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations.
The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.
ANI Pharmaceuticals Inc.
| Country | United States |
| IPO Date | May 5, 2000 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 642 |
| CEO | Nikhil Lalwani |
Contact Details
Address: 210 Main Street West Baudette, Minnesota United States | |
| Website | https://www.anipharmaceuticals.com |
Stock Details
| Ticker Symbol | ANIP |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001023024 |
| CUSIP Number | 00182C103 |
| ISIN Number | US00182C1036 |
| Employer ID | 58-2301143 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Nikhil Lalwani | President, Chief Executive Officer & Director |
| Muthusamy Shanmugam MS R.Ph. | Head of R&D, Chief Operating Officer of Novitium Operations & Director |
| Stephen P. Carey | Senior Vice President of Finance & Chief Financial Officer |
| Chad Gassert | Senior Vice President of Corporate Development & Strategy |
| Christopher K. Mutz | Senior Vice President & Head of Rare Disease |
| Dr. Mary Pao M.D., Ph.D. | Chief Medical Officer |
| Elizabeth Powell J.D. | Chief Compliance Officer & Head of Legal of Rare Disease |
| Krista L. Davis | Senior Vice President & Chief Human Resources Officer |
| Meredith W. Cook J.D. | Senior Vice President, General Counsel & Corporate Secretary |
| Ori Gutwerg | Senior Vice President of Generics |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 13, 2025 | 4 | Filing |
| Jan 13, 2025 | 8-K | Current Report |
| Dec 18, 2024 | 4 | Filing |
| Dec 16, 2024 | 4 | Filing |
| Dec 12, 2024 | 4 | Filing |
| Nov 27, 2024 | 4 | Filing |
| Nov 20, 2024 | 8-K | Current Report |
| Nov 18, 2024 | 4 | Filing |
| Nov 18, 2024 | 4 | Filing |
| Nov 14, 2024 | 4 | Filing |